Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement

Journal of Clinical Virology

Volumn 29, Issue 3, 2004, Pages 179-188

  Ward, C L ^a   Dempsey, M H ^a   Ring, C J A ^a   Kempson, R E ^a   Zhang, L ^a   Gor, D ^a   Snowden, B W ^a   Tisdale, M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Influenza virus; Real time PCR; Validation

Indexed keywords

COMPLEMENTARY DNA; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DILUTION; DYNAMICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZING; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; MEASUREMENT; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE; SENSITIVITY ANALYSIS; STORAGE; THAWING; THROAT CULTURE; TIME; VALIDATION PROCESS; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS LOAD;

EID: 1042275616     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00122-7     Document Type: Article

References (20)

1. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1999;3389-3402.
2. Barnett J.M., Cadman A., Gor D., Dempsey M., Walters M., Candlin A., Tisdale M., Morley P.J., Owens I.J., Fenton R.J., Lewis A.P., Claas E.C.J., Rimmelzwaan G.F., De Groot R., Osterhaus A.D.M.E. Zanamivir susceptibility monitoring and characterisation of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrob. Agents Chemother. 44:2000;78-87.
3. Claas E.C., Osterhaus A.D., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K.F., Webster R.G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 351:1998;472-477.
4. De Vries T.J., Fourkour A., Punt C.J.A., van de Locht L.T.F., Wobbes T., van den Bosch S., de Rooij M.J.M., Mensink E.J.B.M., Ruiter D.J., van Muijen G.N.P. Reproducibility of detection of tyrosine and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. Br. J. Cancer. 80:1999;883-891.
5. Hayden F.G., Palese P. Influenza virus. Rickmann D.D., Whittey R.J., Hayden F.G. Clinical Virology. 1997;Churchill Livingstone, New York.
6. Hayden F.G., Treanor J.J., Betts R.F., Lobo M., Esinhart J.D., Hussey E.K. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 275:1996;295-299.
7. Hayden F.G., Osterhaus A.D., Treanor J.J., Fleming D.M., Aoki F.Y., Nicholson K.G., Bohnen A.M., Hirst H.M., Keene O., Wightman K. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. New Engl. J. Med. 337:1997;874-880.
8. Holland P.M., Abramson R.D., Watson R., Gelfand D.H. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA. 88:1991;7276-7280.
9. Kashiwagi S., Kudoh S., Watanabe A., Yoshimura I. Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza - placebo-controlled double-blind multicenter phase III trial. Kansenshogaku Zasshi - J. Jpn. Assoc. Infect. Dis. 74:2000;1044-1061.
10. Lee L.G., Connell C.R., Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 21:1993;3761-3766.
11. Livak K.J., Flood S.J., Marmaro J., Giusti W., Deetz K. Oligonucleotides with fluorescent dyes at the opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridisation. PCR Methods Appl. 4:1995;357-362.
12. Makela M.J., Pauksens K., Rostila T., Fleming D.M., Man C.Y., Keene O.N., Webster A. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomised, double-blind, placebo-controlled European study. J. Infect. 40:2000;42-48.
13. Monto A.S., Moult A.B., Sharp S.J. Effect of zanamivir on duration and resolution of influenza symptoms. Clin. Ther. 22:2000;1294-1305.
14. Peccoud J., Jacob C. Theoretical uncertainty of measurements using quantitative polymerase chain reaction. Biophys. J. 71:1996;101-108.
15. Puhakka T., Lehti H., Vainionpaa R., Jormanainen V., Pulkkinen M., Sharp S., Kerr C., Dempsey M., Ring C.J., Ward C., Tisdale M. Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza. Scand. J. Infect. Dis. 35:2003;52-58.
16. Schweiger B., Zadow L., Heckler R., Timm H., Pauli G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J. Clin. Microbiol. 38:2000;1552-1558.
17. Stockton J., Ellis J.S., Saville M., Clewley J.P., Zambon M.C. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J. Clin. Microbiol. 36:1998;2990-2995.
18. Treanor J.J., Hayden F.G., Vrooman P.S., Barbarash R., Bettis R., Riff D., Singh S., Kinnersley N., Ward P., Mills R.G. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomised controlled trial. US Oral Neuraminidase Study Group. J. Am. Med. Assoc. 283:2000;1016-1024.
19. van Elden L.J., Nijhuis M., Schipper P., Schuurman R., van Loon A.M. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J. Clin. Microbiol. 39:2001;196-200.
20. Waner J.L., Todd S.J., Shalaby H., Murphy P., Wall L.V. Comparison of directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza virus. J. Clin. Microbiol. 29:1991;479-482.